Search
Oric Pharmaceuticals Inc
ORICAdd to Watchlist
11.070USD
-0.570-4.90%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.15BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
15
analysts
Buy
Current Rating
20.545
Target Price
+82.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Oric Pharmaceuticals Inc
ORIC
15
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Oric Pharmaceuticals Inc's price target?
Analysts forecast that Oric Pharmaceuticals Inc's price target is USD 19.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 12.00.
How have Oric Pharmaceuticals IncORIC's recent earnings per share performed?
The market expectation was USD -0.34, while Oric Pharmaceuticals IncORIC's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.36.
What is the analyst rating for Oric Pharmaceuticals Inc?
Based on the ratings of Oric Pharmaceuticals Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.